# Hemab: Biotechnology, Copenhagen, Denmark

> Hemab: Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

Source: https://millionrounds.com/startup/hemab (Millionrounds; every figure on the page links to its filing or article)

Denmark · [Biotechnology startup](https://millionrounds.com/companies)

# Hemab

Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.

Email

Funding reported Last round: Series B

Biotechnology Copenhagen, Denmark

Follow Hemab and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fhemab)

Company summary

- **Founded:** 2017 9 years old
- **Team:** 11 11 to 50 people
- **Funding reported:** 190M as listed, currency not stated
- **Last round:** Series B Feb 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Hemab has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Hemab raised

Funding, as reported

Reported in all **190M** in the source's currency

Rounds **3**

Last round **Series B**

Last round date **Feb 2023**

Investors listed **9**

## Founders and team

From Hemab's own website: 15 on the team.

- **Angela Volkert** Vice President, Clinical Research
- **Erik Bjornson** Vice President, Regulatory Affairs
- **Karen Weisbach** Chief People and Culture Officer
- **Eva Bøge** Senior Director, Regulatory Affairs
- **Jennifer Dupee** Executive Assistant/Office Manager
- **Keli Walbert** Director
- **Leyna Cho** Senior Clinical Trial Associate
- **Louise Almsgaard Helt** Senior Finance Business Partner
- **Maj Invest Equity** Senior Finance Business Partner
- **Matthew Bandel** Senior Clinical Trial Associate
- **Michelle Fisher** Director, Data Management
- **Per Jeppesen** Director, CMC Drug Product Development
- **Shea Golden** Senior Clinical Trial Associate
- **Shivangi Mathy** Associate Director, Clinical Operations
- **Tara Parsons** Associate Director, Clinical Operations

## On 3 portfolio pages

Investors who name them

- [HealthCap](https://millionrounds.com/fund/healthcap)
- [Avoro Capital Advi...](https://millionrounds.com/fund/avoro-capital-advi)
- [BB Biotech](https://millionrounds.com/fund/bb-biotech)

Each firm lists Hemab on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in Denmark

Startups like it

- [**RetiPharma** Copenhagen · founded 2015 *Raised*](https://millionrounds.com/company/retipharma)
- [**IO Biotech** Copenhagen · founded 2014](https://millionrounds.com/startup/io-biotech)
- [**ADCendo** Copenhagen · founded 2017](https://millionrounds.com/startup/adcendo-2)
- [**Visiopharm** Hoersholm · founded 2001](https://millionrounds.com/startup/visiopharm)
- [**Unibio** Roskilde · founded 2001](https://millionrounds.com/startup/unibio)
- [**Dancann Pharma** Ansager · founded 2018](https://millionrounds.com/startup/dancann-pharma)
- [**Synklino** Lyngby](https://millionrounds.com/startup/synklino)
- [**AFYX Therapeutics** Horsholm · founded 2013](https://millionrounds.com/startup/afyx-therapeutics)

## Is this your company?

Add your raise, your deck and your story, and put Hemab in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)